Werner Hausermann

Title: Werner Hausermann: Innovator in Parkinson's Disease Treatment

Introduction

Werner Hausermann is a notable inventor based in Neuallschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's Disease. His innovative approach has led to the development of a unique process that enhances the preparation of L-Dopa, a crucial agent in managing this debilitating condition.

Latest Patents

Hausermann holds a patent for a process aimed at the preparation of L-Dopa. This invention utilizes D,L-N-benzoyl-3-(4-hydroxy-3-methoxyphenyl) alanine and employs dehydroabietylamine as a resolving agent. The intermediates involved in this process further optimize the production of L-Dopa, showcasing Hausermann's commitment to advancing medical treatments.

Career Highlights

Throughout his career, Werner Hausermann has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has not only contributed to the company's reputation but has also played a vital role in the development of effective treatments for patients suffering from Parkinson's Disease.

Collaborations

Hausermann has collaborated with esteemed colleagues such as Leo Marti and Ado Kaiser. These partnerships have fostered an environment of innovation and have been instrumental in the successful development of his patent.

Conclusion

In summary, Werner Hausermann is a distinguished inventor whose work in the preparation of L-Dopa has made a significant impact on the treatment of Parkinson's Disease. His contributions to the pharmaceutical field continue to inspire advancements in medical science.